Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment
Open accessThe DOI matches its Crossref record; 120 of the 122 references it cites were found in a registry or an index.
Abstract
Melanoma is the deadliest of all skin cancers due to its high metastatic potential. In recent years, advances in targeted therapy and immunotherapy have contributed to a remarkable progress in the treatment of metastatic disease. However, intrinsic or acquired resistance to such therapies remains a major obstacle in melanoma treatment. Melanoma disease progression, beginning from tumor initiation and growth to acquisition of invasive phenotypes and metastatic spread and acquisition of treatment resistance, has been associated with cellular dedifferentiation and the hijacking of gene regulatory networks reminiscent of the neural crest (NC)—the developmental structure which gives rise to melanocytes and hence melanoma. This review summarizes the experimental evidence for the involvement of NC stem cell (NCSC)-like cell states during melanoma progression and addresses novel approaches to combat the emergence of stemness characteristics that have shown to be linked with aggressive disease outcome and drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while some NCSC factors, such as SOX10 and YY1, are activated upon melanoma formation and are required for melanoma growth16,19,29,69”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Our study adds SALL4 to the growing list of stem cell factors known to control melanoma cell biology16.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“there is increasing evidence that the re-expression of NCSC-related factors can regulate melanoma initiation and later stages of the disease, such as resistance to therapies or invasion and metastatic spread16.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Ferroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Le Douarin, N., & Kalcheim, C. (1999) · Cambridge University Press eBooks · doi:10.1017/cbo9780511897948 · Cited by 3,014
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Isolation of multipotent adult stem cells from the dermis of mammalian skin
Toma, J. G., Akhavan, M., Fernandes, K. J. L., Barnabé-Heider, F., Sadikot, A., Kaplan, D. R., & Miller, F. D. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-778 · Cited by 1,593
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Shaffer, S. M., Dunagin, M. C., Torborg, S. R., Torre, E. A., Emert, B., Krepler, C., Beqiri, M., Sproesser, K., Brafford, P. A., Xiao, M., et al. (2017) · Nature · doi:10.1038/nature22794 · Cited by 1,218
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Natural selection of tumor variants in the generation of “tumor escape” phenotypes
Khong, H. T., & Restifo, N. P. (2002) · Nature Immunology · doi:10.1038/ni1102-999 · Cited by 1,058
Tsoi, J., Robert, L., Paraiso, K., Galvan, C., Sheu, K. M., Lay, J., Wong, D. J. L., Atefi, M., Shirazi, R., Wang, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.017 · Cited by 938
Unravelling cancer stem cell potential
Beck, B., & Blanpain, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3597 · Cited by 905
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Sun, C., Wang, L., Huang, S., Heynen, G. J. J. E., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S. M., et al. (2014) · Nature · doi:10.1038/nature13121 · Cited by 888
Isolation of a stem cell for neurons and glia from the mammalian neural crest
Stemple, D. L., & Anderson, D. J. (1992) · Cell · doi:10.1016/0092-8674(92)90393-q · Cited by 806
Feng, D., Wang, K., Wei, Z., Chen, Y.-P., Simon, C. M., Arvapally, R. K., Martin, R. L., Bosch, M., Liu, T.-F., Fordham, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7106 · Cited by 789
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.025 · Cited by 771
In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743
A dermal niche for multipotent adult skin-derived precursor cells
Fernandes, K. J. L., McKenzie, I. A., Mill, P., Smith, K. M., Akhavan, M., Barnabé-Heider, F., Biernaskie, J., Junek, A., Kobayashi, N. R., Toma, J. G., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1181 · Cited by 738
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., Butler, P. D., Yang, G. P., Joshua, B., Kaplan, M. J., et al. (2010) · Nature · doi:10.1038/nature09161 · Cited by 720
Isolation and Characterization of Multipotent Skin‐Derived Precursors from Human Skin
Toma, J. G., McKenzie, I. A., Bagli, D., & Miller, F. D. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0134 · Cited by 678
Establishing neural crest identity: a gene regulatory recipe
Simões-Costa, M., & Bronner, M. E. (2015) · Development · doi:10.1242/dev.105445 · Cited by 649
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Landsberg, J., Kohlmeyer, J., Renn, M., Bald, T., Rogava, M., Cron, M., Fatho, M., Lennerz, V., Wölfel, T., Hölzel, M., et al. (2012) · Nature · doi:10.1038/nature11538 · Cited by 632
Cell lineage analysis reveals multipotency of some avian neural crest cells
Bronner-Fraser, M., & Fraser, S. E. (1988) · Nature · doi:10.1038/335161a0 · Cited by 598
Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin
Adameyko, I., Lallemend, F., Aquino, J. B., Pereira, J. A., Topilko, P., Müller, T., Fritz, N., Beljajeva, A., Mochii, M., Liste, I., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.049 · Cited by 590
Tumor adaptation and resistance to RAF inhibitors
Lito, P., Rosen, N., & Solit, D. B. (2013) · Nature Medicine · doi:10.1038/nm.3392 · Cited by 585
SOX10 Maintains Multipotency and Inhibits Neuronal Differentiation of Neural Crest Stem Cells
Kim, J., Lo, L., Dormand, E., & Anderson, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00163-6 · Cited by 581
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Caramel, J., Papadogeorgakis, E., Hill, L., Browne, G. J., Richard, G., Wierinckx, A., Saldanha, G., Osborne, J., Hutchinson, P., Tse, G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.018 · Cited by 517
DHODH modulates transcriptional elongation in the neural crest and melanoma
White, R. M., Cech, J., Ratanasirintrawoot, S., Lin, C. Y., Rahl, P. B., Burke, C. J., Langdon, E., Tomlinson, M. L., Mosher, J., Kaufman, C., et al. (2011) · Nature · doi:10.1038/nature09882 · Cited by 456
Gene-Regulatory Interactions in Neural Crest Evolution and Development
Meulemans, D., & Bronner-Fraser, M. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.007 · Cited by 450
Natural history of HLA expression during tumour development
Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., & Stern, P. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90264-l · Cited by 448
The melanoma revolution: From UV carcinogenesis to a new era in therapeutics
Lo, J. A., & Fisher, D. E. (2014) · Science · doi:10.1126/science.1253735 · Cited by 427
The melanocyte lineage in development and disease
Mort, R. L., Jackson, I. J., & Patton, E. E. (2015) · Development · doi:10.1242/dev.106567 · Cited by 416
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation
Kaufman, C. K., Mosimann, C., Fan, Z. P., Yang, S., Thomas, A. J., Ablain, J., Tan, J. L., Fogley, R. D., van Rooijen, E., Hagedorn, E. J., et al. (2016) · Science · doi:10.1126/science.aad2197 · Cited by 398
Murakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 396
Pluripotent neural crest stem cells in the adult hair follicle
Sieber‐Blum, M., Grim, M., Hu, Y. F., & Szeder, V. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20129 · Cited by 387
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
Eggermont, A. M. M., & Kirkwood, J. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.030 · Cited by 383
Britsch, S., Li, L., Kirchhoff, S., Theuring, F., Brinkmann, V., Birchmeier, C., & Riethmacher, D. (1998) · Genes & Development · doi:10.1101/gad.12.12.1825 · Cited by 344
Paratore, C., Goerich, D. E., Suter, U., Wegner, M., & Sommer, L. (2001) · Development · doi:10.1242/dev.128.20.3949 · Cited by 338
Self-citationZingg, D., Debbache, J., Schaefer, S. M., Tuncer, E., Frommel, S. C., Cheng, P., Arenas-Ramirez, N., Haeusel, J., Zhang, Y., Bonalli, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7051 · Cited by 334
Self-citationThe Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Zingg, D., Arenas-Ramirez, N., Sahin, D., Rosalia, R. A., Antunes, A. T., Haeusel, J., Sommer, L., & Boyman, O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.007 · Cited by 330
Self-citationCivenni, G., Walter, A., Kobert, N., Mihic-Probst, D., Zipser, M., Belloni, B., Seifert, B., Moch, H., Dummer, R., van den Broek, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3997 · Cited by 326
Self-citationWong, C. E., Paratore, C., Dours-Zimmermann, M. T., Rochat, A., Pietri, T., Suter, U., Zimmermann, D. R., Dufour, S., Thiery, J. P., Meijer, D., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200606062 · Cited by 315
Self-citationRegulation of Msx genes by a Bmp gradient is essential for neural crest specification
Tríbulo, C., Aybar, M. J., Nguyen, V. H., Mullins, M. C., & Mayor, R. (2003) · Development · doi:10.1242/dev.00878 · Cited by 308
Assembling Neural Crest Regulatory Circuits into a Gene Regulatory Network
Betancur, P., Bronner-Fraser, M., & Sauka-Spengler, T. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113245 · Cited by 305
Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
Johnsen, J. I., Dyberg, C., & Wickström, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00009 · Cited by 277
Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma
Shakhova, O., Zingg, D., Schaefer, S. M., Hari, L., Civenni, G., Blunschi, J., Claudinot, S., Okoniewski, M., Beermann, F., Mihic-Probst, D., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2535 · Cited by 274
Self-citationNeural crest progenitors and stem cells: From early development to adulthood
Dupin, E., & Sommer, L. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.02.035 · Cited by 244
Self-citationMelanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
Abel, E. V., Basile, K. J., Kugel, C. H., Witkiewicz, A. K., Le, K., Amaravadi, R. K., Karakousis, G. C., Xu, X., Xu, W., Schuchter, L. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65780 · Cited by 244
Boshuizen, J., Koopman, L. A., Krijgsman, O., Shahrabi, A., van den Heuvel, E. G., Ligtenberg, M. A., Vredevoogd, D. W., Kemper, K., Kuilman, T., Song, J.-Y., et al. (2018) · Nature Medicine · doi:10.1038/nm.4472 · Cited by 229
Langbecker, D., & Janda, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00001 · Cited by 228
Su, Y., Wei, W., Robert, L., Xue, M., Tsoi, J., Garcia-Diaz, A., Homet Moreno, B., Kim, J., Ng, R. H., Lee, J. W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712064115 · Cited by 228
Pre-clinical modeling of cutaneous melanoma
Rebecca, V. W., Somasundaram, R., & Herlyn, M. (2020) · Nature Communications · doi:10.1038/s41467-020-15546-9 · Cited by 228
Mechanisms of Neural Crest Migration
Szabó, A., & Mayor, R. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031559 · Cited by 226
Cancer stem cells and human malignant melanoma
Schatton, T., & Frank, M. H. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00427.x · Cited by 210
Johnston, A. P. W., Yuzwa, S. A., Carr, M. J., Mahmud, N., Storer, M. A., Krause, M. P., Jones, K., Paul, S., Kaplan, D. R., & Miller, F. D. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.002 · Cited by 208
Premigratory and Migratory Neural Crest Cells Are Multipotent In Vivo
Baggiolini, A., Varum, S., Mateos, J. M., Bettosini, D., John, N., Bonalli, M., Ziegler, U., Dimou, L., Clevers, H., Furrer, R., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.017 · Cited by 207
Self-citationDenecker, G., Vandamme, N., Akay, Ö., Koludrovic, D., Taminau, J., Lemeire, K., Gheldof, A., De Craene, B., Van Gele, M., Brochez, L., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.44 · Cited by 206
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
Santini, R., Pietrobono, S., Pandolfi, S., Montagnani, V, D'Amico, M., Penachioni, J. Y., Vinci, M. C., Borgognoni, L., & Stecca, B. (2014) · Oncogene · doi:10.1038/onc.2014.71 · Cited by 201
Injury-activated glial cells promote wound healing of the adult skin in mice
Parfejevs, V., Debbache, J., Shakhova, O., Schaefer, S. M., Glausch, M., Wegner, M., Suter, U., Riekstina, U., Werner, S., & Sommer, L. (2018) · Nature Communications · doi:10.1038/s41467-017-01488-2 · Cited by 200
Self-citationMAP kinase signaling and inhibition in melanoma
Sullivan, R. J., & Flaherty, K. T. (2012) · Oncogene · doi:10.1038/onc.2012.345 · Cited by 173
Adameyko, I., Lallemend, F., Furlan, A., Zinin, N., Aranda, S., Kitambi, S. S., Blanchart, A., Favaro, R., Nicolis, S., Lübke, M., et al. (2012) · Development · doi:10.1242/dev.065581 · Cited by 171
Phenotype Switching in Melanoma: Implications for Progression and Therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163
Schwann cell precursor: a neural crest cell in disguise?
Furlan, A., & Adameyko, I. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.02.008 · Cited by 161
SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues
Mohamed, A., Gonzalez, R. S., Lawson, D., Wang, J., & Cohen, C. (2013) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/pai.0b013e318279bc0a · Cited by 159 · cited 1×
“10 (SOX10), for instance, which regulates the melanocytic and glial murine lineages derived from the NC,(39,40) was found highly expressed in melanocytic nevi and malignant melanoma.(24,68,69) Upon depletion”
BackgroundReinhardt, J., Landsberg, J., Schmid-Burgk, J. L., Ramis, B. B., Bald, T., Glodde, N., Lopez-Ramos, D., Young, A., Ngiow, S. F., Nettersheim, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0395 · Cited by 156
Directed Phenotype Switching as an Effective Antimelanoma Strategy
Sáez‐Ayala, M., Montenegro, M. F., Sánchez‐del‐Campo, L., Fernández-Pérez, M. P., Chazarra, S., Freter, R., Middleton, M. R., Piñero, A., Cabezas‐Herrera, J., Goding, C. R., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.009 · Cited by 147
CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
Menon, D. R., Luo, Y., Arcaroli, J. J., Liu, S., KrishnanKutty, L. N., Osborne, D. G., Li, Y., Samson, J. M., Bagby, S. M., Tan, A. C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0330 · Cited by 146
Wurdak, H., Ittner, L. M., Lang, K. S., Leveen, P., Suter, U., Fischer, J. A., Karlsson, S., Born, W., & Sommer, L. (2005) · Genes & Development · doi:10.1101/gad.317405 · Cited by 141
Self-citationBartolomé, R. A., Gálvez, B. G., Longo, N., Baleux, F., van Muijen, G. N. P., Sánchez-Mateos, P., Arroyo, A. G., & Teixidó, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3398 · Cited by 138
Specific pan-neural crest expression of zebrafishCrestin throughout embryonic development
Luo, R., An, M., Arduini, B. L., & Henion, P. D. (2001) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1097>3.0.co;2-1 · Cited by 135
Divergent differentiation in malignant melanomas: a review
Banerjee, S. S., & Eyden, B. P. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02823.x · Cited by 133
The diverse neural crest: from embryology to human pathology
Etchevers, H., Dupin, É., & Douarin, N. M. L. (2019) · Development · doi:10.1242/dev.169821 · Cited by 129
The Neural Crest Migrating into the Twenty-First Century
Bronner, M. E., & Simões-Costa, M. (2016) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2015.12.003 · Cited by 126
Köhler, C., Nittner, D., Rambow, F., Radaelli, E., Stanchi, F., Vandamme, N., Baggiolini, A., Sommer, L., Berx, G., van den Oord, J. J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.003 · Cited by 126
Self-citationDouble-Edged Sword of Tumour Suppressor Genes in Schizophrenia
Zhuo, C., Wang, D., Zhou, C., Chen, C., Li, J., Tian, H., Li, S., Ji, F., Liu, C., Chen, M., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00001 · Cited by 124
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Boshuizen, J., Vredevoogd, D. W., Krijgsman, O., Ligtenberg, M. A., Blankenstein, S., de Bruijn, B., Frederick, D. T., Kenski, J. C. N., Parren, M., Brüggemann, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17739-8 · Cited by 124
Moon, H., Donahue, L. R., Choi, E., Scumpia, P. O., Lowry, W. E., Grenier, J. K., Zhu, J., & White, A. C. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.09.001 · Cited by 123
Ezh2 is required for neural crest-derived cartilage and bone formation
Schwarz, D., Varum, S., Zemke, M., Schöler, A., Baggiolini, A., Draganova, K., Koseki, H., Schübeler, D., & Sommer, L. (2014) · Development · doi:10.1242/dev.094342 · Cited by 115
Self-citationTumor-Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis
Schatton, T., Scolyer, R. A., Thompson, J. F., & Mihm, M. C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-727-3_16 · Cited by 106
Melanoma revives an embryonic migration program to promote plasticity and invasion
Bailey, C. M., Morrison, J. A., & Kulesa, P. M. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.01025.x · Cited by 103
Requirement for Twist1 in frontonasal and skull vault development in the mouse embryo
Bildsoe, H., Loebel, D. A. F., Jones, V. J., Chen, Y., Behringer, R. R., & Tam, P. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.04.034 · Cited by 101
Single-cell gene expression signatures reveal melanoma cell heterogeneity
Ennen, M., Keime, C., Kobi, D., Mengus, G., Lipsker, D. M., Thibault-Carpentier, C., & Davidson, I. (2014) · Oncogene · doi:10.1038/onc.2014.262 · Cited by 100
Redmer, T., Welte, Y., Behrens, D., Fichtner, I., Przybilla, D., Wruck, W., Yaspo, M.-L., Lehrach, H., Schäfer, R., & Regenbrecht, C. R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092596 · Cited by 98
Ho, Y.-J., Anaparthy, N., Molik, D., Mathew, G., Aicher, T., Patel, A., Hicks, J., & Hammell, M. G. (2018) · Genome Research · doi:10.1101/gr.234062.117 · Cited by 97
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis
Marie, K. L., Sassano, A., Yang, H. H., Michalowski, A. M., Michael, H. T., Guo, T. W., Tsai, Y. C., Weissman, A. M., Lee, M. P., Jenkins, L. M. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14085-2 · Cited by 94
Bogue, C. W., Ganea, G. R., Sturm, E., Iannucci, R., & Jacobs, H. C. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1059>3.0.co;2-# · Cited by 93
The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
Restivo, G., Diener, J., Cheng, P. F., Kiowski, G., Bonalli, M., Biedermann, T., Reichmann, E., Levesque, M. P., Dummer, R., & Sommer, L. (2017) · Nature Communications · doi:10.1038/s41467-017-01573-6 · Cited by 82
Self-citationMelanoma Cells Revive an Embryonic Transcriptional Network to Dictate Phenotypic Heterogeneity
Vandamme, N., & Berx, G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00352 · Cited by 78
Schlegel, N. C., von Planta, A., Widmer, D. S., Dummer, R., & Christofori, G. (2015) · Experimental Dermatology · doi:10.1111/exd.12580 · Cited by 72
Vincentz, J. W., Firulli, B. A., Lin, A., Spicer, D. B., Howard, M. J., & Firulli, A. B. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003405 · Cited by 69
Lehraiki, A., Cerezo, M., Rouaud, F., Abbe, P., Allegra, M., Kluza, J., Marchetti, P., Imbert, V., Cheli, Y., Bertolotto, C., et al. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.30 · Cited by 69
Linked-read sequencing of gametes allows efficient genome-wide analysis of meiotic recombination
Sun, H., Rowan, B. A., Flood, P. J., Brandt, R., Fuß, J., Hancock, A. M., Michelmore, R. W., Hüettel, B., & Schneeberger, K. (2019) · Nature Communications · doi:10.1038/s41467-019-12209-2 · Cited by 68
Sun, Q., Lee, W., Mohri, Y., Takeo, M., Lim, C. H., Xu, X., Myung, P., Atit, R. P., Taketo, M. M., Moubarak, R. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12733-1 · Cited by 68
John, N., Cinelli, P., Wegner, M., & Sommer, L. (2011) · Stem Cells · doi:10.1002/stem.607 · Cited by 67
Self-citationVarum, S., Baggiolini, A., Zurkirchen, L., Atak, Z. K., Cantù, C., Marzorati, E., Bossart, R., Wouters, J., Häusel, J., Tuncer, E., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.011 · Cited by 65
Self-citationBarilani, M., Banfi, F., Sironi, S., Ragni, E., Guillaumin, S., Polveraccio, F., Rosso, L., Moro, M., Astori, G., Pozzobon, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27587-8 · Cited by 61
SMAD signaling promotes melanoma metastasis independently of phenotype switching
Tuncer, E., Calçada, R. R., Zingg, D., Varum, S., Cheng, P. F., Freiberger, S. N., Deng, C., Kleiter, I., Levesque, M. P., Dummer, R., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci94295 · Cited by 61
Self-citationRNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells
Santoriello, C., Sporrij, A., Yang, S., Flynn, R. A., Henriques, T., Dorjsuren, B., Custo Greig, E., McCall, W., Stanhope, M. E., Fazio, M., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0493-0 · Cited by 55
Vega, F. M. D. L., Colmenero-Repiso, A., Gómez-Muñoz, M. A., Rodríguez‐Prieto, I., Morante, D. A., Ramirez, G. L., Márquez-Vega, C., Cabello, R., & Pardal, R. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.041 · Cited by 53
MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression
Heppt, M. V., Wang, J. X., Hristova, D. M., Wei, Z., Li, L., Evans, B., Beqiri, M., Zaman, S., Zhang, J., Irmler, M., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.038 · Cited by 47
Travnickova, J., Wojciechowska, S., Khamseh, A., Gautier, P., Brown, D. V., Lefevre, T., Brombin, A., Ewing, A., Capper, A., Spitzer, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0037 · Cited by 47
Fang, R., Zhang, G., Guo, Q., Ning, F., Wang, H., Cai, S., & Du, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.014 · Cited by 45
SOX10 expression in superficial spreading and nodular malignant melanomas
Agnarsdóttir, M., Sooman, L., Bolander, Å., Strömberg, S., Rexhepaj, E., Bergqvist, M., Pontén, F., Gallagher, W. M., Lennartsson, J., Ekman, S., et al. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e3283403ccd · Cited by 44
Enrichment and Schwann Cell Differentiation of Neural Crest-derived Dental Pulp Stem Cells.
Alzer, H., Apel, C., Heiland, M., Friedrich, R. E., Jung, O., Kroeger, N., Eichhorn, W., & Smeets, R. (2015) · PubMed · Cited by 43
Saltari, A., Truzzi, F., Quadri, M., Lotti, R., Palazzo, E., Grisendi, G., Tiso, N., Marconi, A., & Pincelli, C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.116 · Cited by 40
Johansson, J. A., Marie, K. L., Lu, Y., Brombin, A., Santoriello, C., Zeng, Z., Zich, J., Gautier, P., von Kriegsheim, A., Brunsdon, H., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.013 · Cited by 40
Sox2 is dispensable for primary melanoma and metastasis formation
Schaefer, S. M., Segalada, C., Cheng, P. F., Bonalli, M., Parfejevs, V., Levesque, M. P., Dummer, R., Nicolis, S. K., & Sommer, L. (2017) · Oncogene · doi:10.1038/onc.2017.55 · Cited by 33
Self-citationHumanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells
Morita, S., Mochizuki, M., Wada, K., Shibuya, R., Nakamura, M., Yamaguchi, K., Yamazaki, T., Imai, T., Asada, Y., Matsuura, K., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.011 · Cited by 31
CD271 is a molecular switch with divergent roles in melanoma and melanocyte development
Filipp, F. V., Li, C., & Boiko, A. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-42773-y · Cited by 30
Neuronal lineages derived from the nerve-associated Schwann cell precursors
Kameneva, P., Kastriti, M. E., & Adameyko, I. I. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03609-5 · Cited by 27
Expression of the chicken retinoid X receptor-? gene in migrating cranial neural crest cells
Rowe, A., & Brickell, P. M. (1995) · Anatomy and Embryology · doi:10.1007/bf00186986 · Cited by 26
PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma
Kubic, J. D., Lui, J. W., Little, E. C., Ludvik, A. E., Konda, S., Salgia, R., Aplin, A. E., & Lang, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.670976 · Cited by 25
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo
Cesarini, V., Guida, E., Todaro, F., Agostino, S. D., Tassinari, V., Nicolis, S. K., Favaro, R., Caporali, S., Lacal, P. M., Botti, E., et al. (2017) · Oncogene · doi:10.1038/onc.2017.53 · Cited by 24
Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion
McConnell, A. M., Mito, J. K., Ablain, J., Dang, M., Formichella, L., Fisher, D. E., & Zon, L. I. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.05.026 · Cited by 22
TGFβ superfamily signaling in the neural crest lineage
Conway, S. J., & Kaartinen, V. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.3.15498 · Cited by 18
The convergent roles of CD271/p75 in neural crest-derived melanoma plasticity
Kasemeier‐Kulesa, J. C., & Kulesa, P. M. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.04.008 · Cited by 13
Expression of CD271 in Normal and Malignant Hematopoietic Progenitor and Stem Cells.
Jiang, Y., Powers, J., Muschler, G. F., & Maciejewski, J. P. (2006) · Blood · doi:10.1182/blood.v108.11.4271.4271 · Cited by 1
Cited by
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Oliveira, G., Stromhaug, K., Cieri, N., Iorgulescu, J. B., Klaeger, S., Wolff, J. O., Rachimi, S., Chea, V., Krause, K., Freeman, S. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04682-5 · Cited by 196
Schwann cell precursors represent a neural crest‐like state with biased multipotency
Kastriti, M. E., Faure, L., Ahsen, D. V., Bouderlique, T., Boström, J., Solovieva, T., Jackson, C. R., Bronner-Fraser, M. E., Meijer, D., Hadjab, S., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108780 · Cited by 131
Vats, K., Kruglov, O., Sahoo, B., Soman, V., Zhang, J., Shurin, G. V., Chandran, U. R., Skums, P., Shurin, M. R., Zelikovsky, A., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0110 · Cited by 71
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
Shirley, C. A., Chhabra, G., Amiri, D., Chang, H., & Ahmad, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1336023 · Cited by 62
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Benboubker, V., Boivin, F., Dalle, S., & Caramel, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873116 · Cited by 55
Metadata
- Authors
- Diener, J., & Sommer, L.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Sommer, Lukas
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-01
- Volume
- 10
- Issue
- 4
- Pages
- 522-533
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- PMC
- PMC7980219
- OpenAlex
- W3107037282
- Cited by
- 64
- References
- 122
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 10 · 2023: 12 · 2022: 19 · 2021: 7 · 2020: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 337 d)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells Translational Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- melanoma, neural crest stem cells, cancer stemness, dedifferentiation, treatment resistance, metastasis, gene regulatory networks, melanocyte development, targeted therapy resistance, immunotherapy resistance, disease progression
- MeSH terms
- Humans, Melanocytes, Melanoma, Neural Crest, Disease Progression, Drug Resistance, Neoplasm, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.